Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA. Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis. Journal Of Women's Health 2009, 18: 311-319. PMID: 19281314, PMCID: PMC2858300, DOI: 10.1089/jwh.2008.0857.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsConfidence IntervalsControlled Clinical Trials as TopicFemaleFertilityFertility Agents, FemaleGonadotropin-Releasing HormoneHumansNeoplasmsOdds RatioOvaryPregnancyPregnancy OutcomePrimary Ovarian InsufficiencyPrognosisYoung AdultConceptsFollicle-stimulating hormoneOvarian functionOvarian preservationGnRH agonistGnRHa therapyRelative riskGnRHa-treated womenOvarian function preservationSummary relative riskRandom-effects modelEnglish-language literaturePremenopausal womenCombination chemotherapyRandomized trialsFunction preservationAutoimmune diseasesOvarian failureHematologic malignanciesMenstrual cycleReproductive agePreservation optionsGnRHaChemotherapyMeeting abstractsSmall study